Molecular and clinical study of McArdle’s disease in a cohort of 123 European patients. Identification of 20 novel mutations
- 31 December 2011
- journal article
- Published by Elsevier BV in Neuromuscular Disorders
- Vol. 21 (12), 817-823
- https://doi.org/10.1016/j.nmd.2011.07.002
Abstract
No abstract availableThis publication has 33 references indexed in Scilit:
- Permanent muscle weakness in MCArdle diseaseMuscle & Nerve, 2009
- Phenotype modulators in myophosphorylase deficiencyAnnals of Neurology, 2003
- Spontaneous "Second Wind" and Glucose-Induced Second "Second Wind" in McArdle DiseaseArchives of Neurology, 2002
- Myophosphorylase Deficiency (Glycogenosis Type V McArdle Disease)Current Molecular Medicine, 2002
- Molecular Genetic Heterogeneity of Myophosphorylase Deficiency (McArdle's Disease)The New England Journal of Medicine, 1993
- Intron/exon structure of the human gene for the muscle isozyme of glycogen phosphorylaseProteins: Structure, Function, and Bioinformatics, 1987
- Fatal infantile form of muscle phosphorylase deficiencyNeurology, 1978
- Late-Onset Type of Skeletal-Muscle Phosphorylase DeficiencyThe New England Journal of Medicine, 1963
- CHRONIC PROGRESSIVE MYOPATHY WITH MYOGLOBINURIA: DEMONSTRATION OF A GLYCOGENOLYTIC DEFECT IN THE MUSCLE*JCI Insight, 1959
- A FUNCTIONAL DISORDER OF MUSCLE ASSOCIATED WITH THE ABSENCE OF PHOSPHORYLASEProceedings of the National Academy of Sciences of the United States of America, 1959